Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

MAR 21, 2013 - Benzinga

A Must Read - Share

UPDATE: Cantor Fitzgerald Downgrades Obagi Medical Products to Hold on Merger News

Cantor Fitzgerald analyst published a report on Obagi Medical Products (NASDAQ OMPI) that lowered its rating from Buy to Hold and raised its price target from $19.00 to $19.75. Cantor Fitzgerald reported that, "On March 20, Valeant announced that it had entered an agreement to purchase Obagi for $360 million, or $19.75/share, a 28% premium to the prior day's closing price.

Tags: UPDATE: Cantor Fitzgerald Downgrades Obagi Medical Products to Hold on Merger News,  Cantor Fitzgerald Latest News